Interferon Therapy for Kaposi Sarcoma Associated with Acquired Immunodeficiency Syndrome: Still a Valid Treatment Option?
Authors:
- 1 October 2013
- journal article
- research article
- Published by SAGE Publications in AIDS Patient Care and STDs
- Vol. 27 (10) , 537-538
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Kaposi's Sarcoma in HIV-Infected Women and Men in NigeriaAIDS Patient Care and STDs, 2011
- Complete clinical and virological remission of refractory HIV-related Kaposi's sarcoma with pegylated interferon alphaAIDS, 2007
- Management of AIDS-related Kaposi's sarcomaThe Lancet Oncology, 2007
- Interferon-α2b With Protease Inhibitor-Based Antiretroviral Therapy in Patients With AIDS-Associated Kaposi SarcomaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-αLeukemia Research, 2005
- Effects of Interferon Alpha on Vascular Endothelial Growth Factor Gene Transcription and Tumor AngiogenesisJNCI: Journal of the National Cancer Institute, 2003
- Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphomaThe Lancet Infectious Diseases, 2002
- Classic Kaposi’s Sarcoma: Low-Dose Interferon Alfa TreatmentDermatology, 1998
- CLINICAL AND VIROLOGICAL EFFECTS OF HIGH-DOSE RECOMBINANT INTERFERON-α IN DISSEMINATED AIDS-RELATED KAPOSI'S SARCOMAThe Lancet, 1988
- Synergistic Interaction of 2',3'-Dideoxycytidine and Recombinant Interferon- -A on Replication of Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 1988